Clinical, Physiological and Anti-Inflammatory Effect of Montelukast in Patients with Cough Variant Asthma | Zendy

Masaya Takemura | Zendy; Akio Niimi | Zendy; Hisako Matsumoto | Zendy; Tetsuya Ueda | Zendy; Hirofumi Matsuoka | Zendy; Masafumi Yamaguchi | Zendy; Makiko Jinnai | Zendy; Kazuo Chin | Zendy; Michiaki Mishima | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical, Physiological and Anti-Inflammatory Effect of Montelukast in Patients with Cough Variant Asthma

Author(s) -

Masaya Takemura,

Akio Niimi,

Hisako Matsumoto,

Tetsuya Ueda,

Hirofumi Matsuoka,

Masafumi Yamaguchi,

Makiko Jinnai,

Kazuo Chin,

Michiaki Mishima

Publication year - 2011

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000332835

Subject(s) - medicine , montelukast , methacholine , asthma , eosinophil , leukotriene , bronchial hyperresponsiveness , sputum , leukotriene d4 , visual analogue scale , anesthesia , spirometry , salmeterol , gastroenterology , leukotriene receptor , bronchodilator , respiratory disease , lung , pathology , tuberculosis

Cough variant asthma (CVA) is a phenotype of asthma presenting solely with coughing, characterized by airway hyperresponsiveness, eosinophilic inflammation and a cough response to bronchodilators. Leukotriene receptor antagonists (LTRAs) are antiasthma medications with anti-inflammatory and bronchodilatory properties. Although LTRAs exert antitussive effects in CVA, the mechanisms involved are unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research